ResourceLife Sciences
Automation and high content imaging of 3D triple-negative breast cancer patient-derived tumoroids assay for compound screening
30 Oct 2024This application note describes methods and demonstrates tools that increase throughput and automation in 3D cancer assays and compound screening. In addition, it shows advanced analysis approaches and descriptors that allow scientists to gain more information about complex cellular systems, disease phenotypes, and compound effects.